Global Tuberculosis Diagnostics Testing Market Growth (Status and Outlook) 2024-2030

Global Tuberculosis Diagnostics Testing Market Growth (Status and Outlook) 2024-2030

Tuberculosis diagnostic testing is the process of detecting Mycobacterium tuberculosis infection and evaluating disease status through a range of methods, such as skin tests, sputum sample analysis, imaging and blood tests, and molecular biology techniques. These tests help to confirm the presence and type of TB.

The global Tuberculosis Diagnostics Testing market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Tuberculosis Diagnostics Testing Industry Forecast” looks at past sales and reviews total world Tuberculosis Diagnostics Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Tuberculosis Diagnostics Testing sales for 2023 through 2029. With Tuberculosis Diagnostics Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis Diagnostics Testing industry.

This Insight Report provides a comprehensive analysis of the global Tuberculosis Diagnostics Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tuberculosis Diagnostics Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tuberculosis Diagnostics Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis Diagnostics Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis Diagnostics Testing.

United States market for Tuberculosis Diagnostics Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Tuberculosis Diagnostics Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Tuberculosis Diagnostics Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Tuberculosis Diagnostics Testing players cover Abbott Laboratories, Becton, Dickinson and Company (BD), BioMerieux SA, Cepheid (Danaher Corporation), Hologic, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Diagnostics Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Diagnostic Laboratory
Molecular Diagnostics
Cytokine Detection Assay
Others

Segmentation by Application:
Medical Diagnosis
Epidemiologic Investigations
Public Health Control
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Diagnostic Laboratory
Molecular Diagnostics
Cytokine Detection Assay
Others

Segmentation by Application:
Medical Diagnosis
Epidemiologic Investigations
Public Health Control
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Becton, Dickinson and Company (BD)
BioMerieux SA
Cepheid (Danaher Corporation)
Hologic, Inc.
Hain Lifescience GmbH
Oxford Immunotec (PerkinElmer)
Qiagen N.V.
Roche Molecular Systems Inc.
Siemens Healthineers AG
Thermo Fisher Scientific Inc.

Please note: The report will take approximately 2 business days to prepare and deliver.